Blackford Analysis

Edinburgh, United Kingdom Acquired By Bayer
Image comparison and analysis software is provided for medical workflows.

About Blackford Analysis

Blackford Analysis is a Healthcare company based in Edinburgh (United Kingdom), and was acquired by Bayer in January 2023. Image comparison and analysis software is provided for medical workflows. Blackford Analysis has raised $2.21 million across 3 funding rounds from investors including Bayer, Scottish Enterprise and Tri-CAP. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is BLACKFORD ANALYSIS LIMITED.

Company details

Medical imaging software is developed by Blackford Analysis, based in Edinburgh, United Kingdom, to support hospital workflows. Algorithms for real-time analysis of datasets, including hyperspectral and image data, are created. The platform, originally adapted from spectral analysis in astrophysics, processes data to streamline operations in the healthcare sector. Focus is placed on efficiency in clinical environments across the UK and beyond.

  • Headquarters Edinburgh, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Website blackfordanalysis.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Bayer (Jan 2023)
  • Legal Name Blackford Analysis Limited
  • Date of Incorporation 14 Jun, 2010
  • Jurisdiction EDINBURGH, SCOTLAND
Key Metrics
  • Total Equity Funding
    $2.21M (USD)

    in 3 rounds

  • Latest Funding Round
    $937K (USD), Angel Round

    Feb 2016

  • Investors
    Bayer

    & 4 more

  • Acquired by
    Bayer

    (Jan 2023)

Apps and channels of Blackford Analysis

its YouTube channel Blackford Analysis has 132 subscribers and 30 videos.

Blackford Analysis
YouTube 132 subscribers 30 videos Science & Technology
Open channel

Videos from Blackford Analysis

The most watched videos on Blackford Analysis's YouTube channel, Blackford Analysis (132 subscribers). Click a video to play it here.

Blackford Explainer Video
10.5K views
Maximize the success of AI with the Blackford Platform
372 views
How can AI enhance cardiovascular imaging?
192 views
Staying abreast of progress | Webinar - Part 1
187 views

More on Blackford Analysis.

Funding Insights of Blackford Analysis

Blackford Analysis has successfully raised a total of $2.21M across 3 strategic funding rounds. The most recent funding activity was a Angel Round of $937 thousand completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.21M
  • Total Rounds 3
  • Last Round Angel Round β€” $937,000
  • First Round $1.27M

    (Sep 2012)

  • Investors Count 4

All 3 funding rounds of Blackford Analysis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2016$937,000Angel Round––
Jun 2014Series A––
Sep 2012$1.27MSeed––
Valuation history

5 investors in total: 5 institutional.

Investors in Blackford Analysis

Blackford Analysis has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Bayer, Scottish Enterprise and Tri-CAP.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investment and expertise are provided to early-stage Scottish companies.
archangelsonline.comEdinburgh, Scotland
oldcollegecapital.co.uk
Business development and leadership training programs are offered to companies.
1991scottish-enterprise.comGlasgow, United Kingdom
Community welfare in Minnesota is supported by a government agency.
1965tricap.orgWaite Park, United States
Life science solutions for healthcare and agriculture are delivered.
1863bayer.comLeverkusen, Germany
Premium access

Investor details for Blackford Analysis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Blackford Analysis

36 people are tracked at Blackford Analysis (11 in leadership, 25 in team).

NameRoleGroup
Matt Crollard
North-Western Enterprise Sales DirectorLeadership
David Hilderbrand
Executive Vice President RevenueLeadership
James Holroyd
Managing DirectorLeadership
Laura Henderson
VP Of People & Executive OfficeLeadership
Stuart Bisset
Head Of Finance TransformationLeadership
Laura Crichton
People & Culture PartnerLeadership
Mary Hoxworth
Vice President of Product MarketingLeadership
Evie (Yvonne) Eccles
VP QARC (Quality Assurance & Regulatory Compliance)Leadership
David Middleton
VP Of EngineeringLeadership
Anthony Cammack
Director, VA & Government AccountsLeadership
Neil Pollock
Head Of IT InfrastructureLeadership
Chris Lyttle
Software Team LeadTeam
John R.
Quality Assurance & Regulatory Compliance EngineerTeam
Craig Flood
SVP CommercialTeam
Greig Hyslop
Technical Deployment LeadTeam
Tom McCluskey
Senior Product Manager - PortfolioTeam
Claire Spurrell
Product ManagerTeam
John Gregor
Technology LeadTeam
Angus Sturrock
Programme ManagerTeam
Huia Mitchell
Clinical AI ConsultantTeam

16 more people are available in the full profile.

Premium access

Complete people profiles for Blackford Analysis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Blackford Analysis

3 dated milestones of Blackford Analysis across 11 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $1.3M.
  2. Funding Latest funding round, Angel Round, of $937K.
  3. Exit Acquired by Bayer.

Web traffic of Blackford Analysis

The website of Blackford Analysis (blackfordanalysis.com) receives about 6.5K visits a month.

  • Monthly visits
    6.5K

    ▼ 18.2% vs previous month

Similar websites

Websites whose visitors overlap most with Blackford Analysis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
piemedicalimaging.com
100%
#3,046,527View details
image-iq.com
62%
View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Blackford Analysis

Premium access

Complete news archive for Blackford Analysis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Blackford Analysis

Blackford Analysis is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.

Blackford Analysis is a funded company, having raised a total of $2.21M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.27M, raised on Sep 2012.

Medical imaging software is developed by Blackford Analysis, based in Edinburgh, United Kingdom, to support hospital workflows. Algorithms for real-time analysis of datasets, including hyperspectral and image data, are created. The platform, originally adapted from spectral analysis in astrophysics, processes data to streamline operations in the healthcare sector. Focus is placed on efficiency in clinical environments across the UK and beyond.

Blackford Analysis has 5 investors. Key investors include Bayer, Scottish Enterprise, Tri-CAP, Archangels, and Old College Capital.

Blackford Analysis operates through Blackford Analysis Limited.

Yes. Blackford Analysis was acquired by Bayer in January 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available